Canada Goose Holdings Inc.
GOOSAbout the company
Canada Goose Holdings Inc., together with its subsidiaries, designs, manufactures, and sells performance luxury outerwear, apparel, footwear, and accessories for men, women, youth, children, and babies. It operates through three segments: Direct-to-Consumer, Wholesale, and Other.
Investment snapshot
Positive
3
BUY / PASS
Neutral / negative
8 / 4
NEUTRAL / FAIL
Median fair value
$11.39
+47.8% vs price
Models with upside
10 / 16
Positive margin of safety
Strongest signal
All 10 investors pass GOOS's cash flow
Key risk
10 of 15 flag GOOS's profitability — Sleep, Oshaughnessy, Lynch +7 more
Framework analysis
| Verdict | Meaning |
|---|---|
| BUY | Positive purchase signal: the framework's buy requirements are met. |
| PASS | The company clears the framework's checklist or screen, but the framework does not produce a buy signal. For valuation frameworks this often means margin of safety is missing, insufficient, or unavailable; some screen-only frameworks have no intrinsic-value BUY state. |
| NEUTRAL | Neither a positive nor negative conclusion. It does not mean to hold an existing position. |
| FAIL | The company does not clear the framework's requirements. |
| Ranked | Ranked strategies do not use PASS: selected cohort is BUY, outside the cohort is FAIL, and unranked is NEUTRAL. |
| Metric | Sleep Scale Economies Shared | O'Shaughnessy Systematic Factor Composite | Lynch GARP | Buffett Quality Compounder | Pabrai Dhandho Framework | Akre Three-Legged Stool | Schloss Asset-Value Discipline | Neff Low-P/E Total Return | Templeton Global Bargain Hunter | Marks Risk-Aware Value | Munger Quality Focus | Ackman Activist Value | Dreman Contrarian Value | Piotroski F-Score | Greenblatt Magic Formula | Graham Defensive Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Verdict | NEUTRAL | NEUTRAL | FAIL | PASS | NEUTRAL | FAIL | NEUTRAL | FAIL | NEUTRAL | NEUTRAL | FAIL | PASS | NEUTRAL | NEUTRAL | BUY · Rank #192 (Top 6%) | PASS |
| Score | ||||||||||||||||
| Analysis | ||||||||||||||||
| Intrinsic Value | N/A | N/A | N/A | N/A | N/A | N/A | ||||||||||
| Margin of Safety | N/A | N/A | N/A | +68.8% | +45.6% | +61.0% | N/A | N/A | +8.4% | +10.5% | +85.8% | +72.4% | +4.2% | N/A | +10.2% | +0.1% |
| Data As Of | 10-K (2026-08-26) | 10-K (2026-08-25) | 10-K (2026-08-25) | 10-K (2026-08-25) | 10-K (2026-08-25) | 10-K (2026-08-25) | 10-K (2026-08-24) | 10-K (2026-08-24) | 10-K (2026-08-23) | 10-K (2026-08-23) | 10-K (2026-08-23) | 10-K (2026-08-23) | 10-K (2026-08-23) | 10-K (2026-08-23) | 10-K (2026-08-23) | 10-K (2026-08-23) |
Where It Passes
- Cash Flow100% pass✓ 12▾
All 10 investors pass GOOS's cash flow
Positive Operating Cash Flow frequency9/10 years positive✓SleepPositive OCF in >= 70% of available years(Operating cash flow - capex) / market capitalization+25.72%; #198/4487 (top 4.4%)✓OshaughnessyTop 10% of eligible cross-sectionFCF Positive and Growing$192.0M✓LynchPositive and growingFree Cash Flow Proxy$138.9M✓BuffettPositive and growingP/E or FCF YieldP/E=11.4x, FCF Yield=25.7%✓PabraiP/E < 15 or FCF Yield > 10%Operating Cash Flow - Capital Expenditures$192.0M✓Neff> $0 (app proxy for a strong fundamental case)FCF Positive9/10 years FCF positive✓MarksPositive FCF in majority of recent years(OCF - CapEx) / Market Cap25.7%✓Ackman>= 4%Price / FCF per Share3.9x✓Ackman<= 25Price / (CFO / Shares)3.7x✓Dreman< 8xOperating Cash Flow$204.4M✓PiotroskiCFO > 0(CFO / Total Assets) vs ROACFO/Assets=18.09%, ROA=5.86%✓PiotroskiCFO/Assets > ROA - Valuation models100% pass✓ 10▾
GOOS undervalued: all 10 models price fair value above $7.71 (median $11.39)
Buffett fair value$24.72✓Buffett+68.8% margin vs $7.71Pabrai fair value$14.18✓Pabrai+45.6% margin vs $7.71Akre fair value$19.77✓Akre+61.0% margin vs $7.71Templeton fair value$8.42✓Templeton+8.4% margin vs $7.71Marks fair value$8.61✓Marks+10.5% margin vs $7.71Munger fair value$54.24✓Munger+85.8% margin vs $7.71Ackman fair value$27.94✓Ackman+72.4% margin vs $7.71Dreman fair value$8.05✓Dreman+4.2% margin vs $7.71Greenblatt fair value$8.59✓Greenblatt+10.2% margin vs $7.71Graham fair value$7.72✓Graham+0.1% margin vs $7.71 - Efficiency63% pass✓ 8✗ 3▾
5 of 8 pass — Akre, Munger and Piotroski object
ROIC (5-year)4/5 years above 12% (latest 14.9%)✓SleepROIC > 12% in a majority of yearsROIC (3-5 yr avg)24.3%✓Buffett> 10%ROIC - WACC+14.3%✓BuffettPositive (WACC = 10%)ROIC (high and growing)FY2022: ROIC=14.5%; FY2023: ROIC=13.2%; FY2024: ROIC=14.9%✗AkreLatest 3 consecutive FYs: ROIC > 15% in eachReinvestment Rate x ROIC14.9% (RR=100% x ROIC=14.9%)✓AkreReinvestment Rate * ROIC > 10%Return on Invested Capital14.9%✗Munger> 15%Current Assets / Current Liabilities2.67✓Dreman> 1.5Current Ratio Change YoY2.23 -> 2.67✓PiotroskiIncreased YoYRevenue / Total Assets Change YoY0.90x -> 0.83x✗PiotroskiImproved YoYEBIT / (NWC + Net Fixed Assets)43.9%✓Greenblatt> 25%Current Ratio2.67✓Graham>= 2.0 - Debt & Leverage55% pass✓ 8✗ 6▾
6 of 11 pass — Lynch, Buffett, Akre +2 more object
Total Debt / Equity0.61✗Lynch< 0.33Cash - Long-term Debt✗LynchPositive preferredDebt/Equity & Interest CoverageD/E: 0.61, IC: N/A✗BuffettD/E < 0.5 AND Interest Coverage > 5xDebt Levels0.61✗AkreDebt/Equity < 0.3✗MungerDebt/Equity < 0.5Total Debt / Shareholders' Equity0.61x✓SchlossD/E < 1.00x✓Templeton< 1.0 (fixed cap; proxy for below-sector-median leverage)✓Dreman< 0.8Current Assets / Current Liabilities2.67x✓SchlossCurrent ratio >= 1.50x (app cutoff)✓Dreman> 1.5Interest Coverage & Debt/EBITDAIC=N/A (no interest expense), D/EBITDA=1.2x✓MarksInterest Coverage > 3x; Debt/EBITDA < 4xTotal Debt / Shareholders Equity0.61✓Ackman<= 1.0LT Debt / Total Assets Change0.00% -> 0.00%✓PiotroskiDecreased YoYLT Debt vs Net Current Assets✗GrahamLT Debt <= Net Current Assets
Where It Falls Short
- Profitability33% pass✓ 17✗ 14▾
10 of 15 flag GOOS's profitability — Sleep, Oshaughnessy, Lynch +7 more
Revenue growth vs. gross and operating margin trendgross margin 67.0% -> 69.9%, operating margin 12.1% -> 12.2%✗SleepRevenue rising; gross margin flat or falling; operating margin holdingNet income / market capitalization+8.87%; #720/6251 (top 11.5%)✗OshaughnessyTop 10% of eligible cross-sectionBasic earnings-growth PEG (dividends excluded)P/E 11.4x (growth N/A)✗Lynch< 1.0 (ideally < 0.5)3-5 Year EPS CAGR-6.9%✗Lynch15-30% (Fast Grower); > 0% to passROE17.5%✓Lynch> 15%Net Income Positive (10+ years)10/11 years positive✗BuffettPositive every year for 10+ yearsROE (up to 5-year arithmetic mean)16.3%✓Buffett> 15% arithmetic mean (app rule)Operating Margin (10-yr trend)12.2% (latest)✗BuffettStable or rising over 10 yearsFree Cash Flow Proxy$138.9M✓BuffettPositive and growingEarnings Variance (10-yr CoV)0.45✗BuffettCoV < 0.3Retained Earnings Effectiveness✗Buffett$1 retained -> > $1 market value createdMargin of SafetyP/E=11.4x, P/B=2.0x✓PabraiP/B < 1.5 or P/E < 15Return on Equity15.7% (3-yr avg)✗AkreROE > 20% (3-year avg)Positive Diluted-EPS Years10/10 years positive✓Schloss>= 70% positive over 5-10 observed years (app rule)3-5 Year Diluted EPS CAGR-6.9% over 5 years✗Neff7%-20% annualized5-Year EPS CAGR-6.9% CAGR over 5 years✗Templeton> 0% (5-year EPS CAGR)Operating Margin Trend12.1% (2022) -> 12.2% (2024)✓TempletonNon-negative operating-margin trend over 3 yearsDiscount to Intrinsic Value4.2% (IV=$8.05 vs Price=$7.71)✗Marks>= 20% below intrinsic valuePositive Net Income Frequency10/10 years positive✓MarksPositive net income in >= 7 of last 10 yearsOperating Income / Revenue12.2%✗Ackman>= 15%Net Income / Shareholders Equity17.5%✓Ackman>= 15%Pre-Tax Income / Revenue9.5%✓Dreman>= 8%Net Income / Shareholders' Equity17.5%✓Dreman> 12%Net Income / Total Assets5.86%✓PiotroskiROA > 0ROA Change YoY3.94% -> 5.86% (delta: +1.92%)✓PiotroskiCurrent ROA > Prior ROA(CFO / Total Assets) vs ROACFO/Assets=18.09%, ROA=5.86%✓PiotroskiCFO/Assets > ROAGross Margin Change YoY68.8% -> 69.9%✓PiotroskiImproved YoYEBIT / Enterprise Value15.4%✓Greenblatt> 10%Earnings Yield + ROC AssessmentEY=15.4%, ROC=43.9%✓GreenblattBoth EY > 10% and ROC > 25%Positive EPS (10 years)10/11 years positive✗GrahamPositive EPS every year for 10 yearsEPS Growth (3-yr avg, 10-yr window)199.8%✓Graham>= 33% growth - Valuation33% pass✓ 14✗ 12▾
8 of 12 flag GOOS's valuation — Oshaughnessy, Lynch, Schloss +5 more
Revenue / market capitalization+1.2623; #1411/5203 (top 27.1%)✗OshaughnessyTop 10% of eligible cross-sectionNet income / market capitalization+8.87%; #720/6251 (top 11.5%)✗OshaughnessyTop 10% of eligible cross-section(Operating cash flow - capex) / market capitalization+25.72%; #198/4487 (top 4.4%)✓OshaughnessyTop 10% of eligible cross-sectionTrailing six-month price return through the evaluation date-29.72%; #5000/6203 (top 80.6%)✗OshaughnessyTop 10% of eligible cross-sectionBasic earnings-growth PEG (dividends excluded)P/E 11.4x (growth N/A)✗Lynch< 1.0 (ideally < 0.5)P/E or FCF YieldP/E=11.4x, FCF Yield=25.7%✓PabraiP/E < 15 or FCF Yield > 10%Price / Book Value per Share1.97x✗SchlossP/B <= 0.80x (app cutoff)✗Templeton< 1.5x✗Dreman< 1.2xPrice / Tangible Book Value per Share3.17x✗SchlossP/TBV <= 1.00x (app cutoff)Book Value per Share Change+21.3%✓SchlossLatest BVPS >= earliest BVPS over >= 3 years (app rule)Price / Diluted EPS11.4x✓NeffP/E <= 15x (app proxy for a P/E 40%-60% below the market)(EPS CAGR % + Dividend Yield %) / P/E✗Neff> 0.7 (Neff's published traditional edge)Price / EPS11.4x✓Templeton< 12x (fixed ceiling; proxy for the market's cheapest 40%)✓Dreman< 12xPrice vs. Trailing Low100% of trailing low ($7.71)✓Templeton<= 120% of trailing low (certified split-adjusted live window)P/B or P/E vs. Historical AverageP/E=11.4x, P/B=2.0x✓MarksP/E < 15 or P/B < 2.0Discount to Intrinsic Value4.2% (IV=$8.05 vs Price=$7.71)✗Marks>= 20% below intrinsic valueValuation ReasonablenessP/E=11.4x, OE Yield=18.6%✓MungerP/E < 25 or Owner Earnings Yield > 5%Price / FCF per Share3.9x✓Ackman<= 25Price / (CFO / Shares)3.7x✓Dreman< 8xEBIT / Enterprise Value15.4%✓Greenblatt> 10%Earnings Yield + ROC AssessmentEY=15.4%, ROC=43.9%✓GreenblattBoth EY > 10% and ROC > 25%Price / 3-yr avg EPS14.4x✓Graham<= 15xPrice-to-Book Ratio2.0x✗Graham<= 1.5xP/E x P/B28.40✗Graham<= 22.5 - Growth38% pass✓ 5✗ 8▾
5 of 8 flag GOOS's growth — Sleep, Lynch, Neff +2 more
Revenue growth vs. gross and operating margin trendgross margin 67.0% -> 69.9%, operating margin 12.1% -> 12.2%✗SleepRevenue rising; gross margin flat or falling; operating margin holding5-year Revenue CAGR6.7%✗SleepCAGR > 7%Basic earnings-growth PEG (dividends excluded)P/E 11.4x (growth N/A)✗Lynch< 1.0 (ideally < 0.5)3-5 Year EPS CAGR-6.9%✗Lynch15-30% (Fast Grower); > 0% to passInventory Growth vs Revenue GrowthInv: -18.4% vs Rev: -4.4%✓LynchInventory growth < Revenue growth3-5 Year Diluted EPS CAGR-6.9% over 5 years✗Neff7%-20% annualized5-Year EPS CAGR-6.9% CAGR over 5 years✗Templeton> 0% (5-year EPS CAGR)Positive Net Income Frequency10/10 years positive✓MarksPositive net income in >= 7 of last 10 years3yr Median Revenue Growth2.4%✗Ackman>= 5%Positive EPS Growth Frequency2/5 years with positive EPS growth✗AckmanPositive EPS growth in >= 3 of last 5 yearsEPS Growth Direction$0.20 (2015) -> $0.68 (2024)✓DremanPositive over recent yearsEPS CAGR14.5% CAGR over 9 years✓Dreman> 5% annualizedEPS Growth (3-yr avg, 10-yr window)199.8%✓Graham>= 33% growth - Verdicts50% pass✓ 4✗ 4▾
Split decision: 8 NEUTRAL · 4 FAIL · 3 PASS
Overall verdict•SleepNEUTRAL (4/6)•OshaughnessyNEUTRAL (Not ranked)✗LynchFAIL (3/7)✓BuffettPASS (4/9)•PabraiNEUTRAL (2/3)✗AkreFAIL (2/6)•SchlossNEUTRAL (4/7)✗NeffFAIL (3/6)•TempletonNEUTRAL (5/8)•MarksNEUTRAL (4/5)✗MungerFAIL (1/4)✓AckmanPASS (5/9)•DremanNEUTRAL (8/11)•PiotroskiNEUTRAL (F-Score 7)✓GreenblattRank #192✓GrahamPASS (4/9)
Business & financials
Company Profile
Financial Snapshot
Shareholder Return
Fiscal 2024
Issued 0.3% of shares last year, 7.1% over two.
- Buybacks
- $0
- Dividends
- —
What drove EPS
A buyback raises earnings per share without the company earning more. This splits each year's change into the two.
The two parts do not sum exactly to the total — the difference is the cross-term, plus preferred capital where the company has any. It is left visible rather than distributed into the other two.
Share count is the denominator the filer used for diluted EPS, recovered as net income ÷ EPS — not the balance-sheet count, which is a point-in-time figure and would put the timing difference into this split. Years with a loss are omitted: a smaller share count makes a loss per share larger, so the decomposition inverts.
Company Financials
Annual data (10-K) · Last 5 years
| Metric | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Market Cap | $746.6M | $1.2Best. | $2.5Best. | $3.2Best. | $3.7Best. |
| Revenue | $942.4M↓4% | $985.4M↑9% | $900.0M↑2% | $878.8M↑23% | $717.1M |
| Operating Income | $114.7M↑25% | $92.0M↓16% | $109.2M↓14% | $127.6M↑37% | $92.8M |
| Net Income | $66.3M↑54% | $43.1M↓20% | $53.8M↓29% | $75.7M↑36% | $55.8M |
| EPS (Diluted) | $0.68↑61% | $0.42↓17% | $0.51↓27% | $0.70↑39% | $0.50 |
| Gross Margin | 69.9%↑2% | 68.8%↑3% | 67.0% | 66.8%↑9% | 61.3% |
| Operating Margin | 12.2%↑30% | 9.3%↓23% | 12.1%↓16% | 14.5%↑12% | 12.9% |
| ROE | 17.5%↑25% | 14.0%↓10% | 15.5%↓30% | 22.1%↑82% | 12.2% |
| Total Debt | $231.2M↓5% | $244.2M↓1% | $247.6M↑23% | $200.6M↓1% | $202.2M |
| Shareholders' Equity | $378.3M↑23% | $308.1M↓11% | $347.2M↑1% | $342.4M↓25% | $458.3M |
| Current Ratio | 2.67↑20% | 2.23↓9% | 2.45↓10% | 2.71↓21% | 3.42 |
| Debt / Equity | 0.61↓23% | 0.79↑11% | 0.71↑22% | 0.59↑33% | 0.44 |
| Operating Cash Flow | $204.4M↑68% | $121.6M↑41% | $86.0M↓29% | $121.3M↓47% | $229.0M |
| Free Cash Flow | $192.0M↑137% | $81.0M↑54% | $52.6M↓44% | $93.7M↓55% | $207.7M |
Score history
Historical Score Timeline
Industry peers
Industry Peers
Similar companies in Apparel
GOOS vs Peers — Financial Grading
| Company | Market Cap | Price | Revenue | Net Income | ROE | D/E | Op. Margin | Curr. Ratio | Graham | Buffett | Lynch | Greenblatt | Piotroski | Dreman |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CINTAS CORPCTAS | $79.0B | $197.74 | $10.3B | $1.8B | 38.7% | 0.52 | 22.8% | 2.09 | 3/9 | 5/9 | 1/7 | 1/3 | F-Score 5 | 5/11 |
| TAPESTRY, INC.TPR | $22.8B | $114.12 | $7.0B | $183.2M | 21.4% | 2.79 | 5.9% | 1.87 | 1/9 | 3/9 | 1/7 | 0/3 | F-Score 5 | 3/11 |
| Amer Sports, Inc.AS | $15.2B | $27.24 | $6.6B | $427.4M | 7.4% | 0.14 | 10.7% | 1.50 | 2/9 | 3/9 | 2/7 | 1/3 | F-Score 7 | 4/11 |
| DECKERS OUTDOOR CORPDECK | $10.8B | $77.68 | $5.5B | $1.0B | 41.0% | — | 23.1% | 3.54 | 2/9 | 5/9 | 3/7 | 3/3 | F-Score 7 | 5/11 |
| lululemon athletica inc.LULU | $10.7B | $96.87 | $11.1B | $1.6B | 31.8% | 0.00 | 19.9% | 2.26 | 4/9 | 5/9 | 3/7 | 3/3 | F-Score 4 | 5/11 |
| On Holding AGONON | $9.9B | $29.55 | $3.8B | $257.3M | 12.5% | 0.32 | 12.5% | 2.71 | 2/9 | 5/9 | 2/7 | 1/3 | F-Score 7 | 4/11 |
| Gildan Activewear Inc.GIL | $7.9B | $42.62 | $3.6B | $398.9M | 11.2% | 1.21 | 17.1% | 2.11 | 3/9 | 5/9 | 1/7 | 0/3 | F-Score 4 | 5/11 |
| LEVI STRAUSS & COLEVI | $7.6B | $19.75 | $6.3B | $578.1M | 25.4% | 0.46 | 10.8% | 1.55 | 3/9 | 5/9 | 2/7 | 1/3 | F-Score 7 | 5/11 |